David DeLucia

CIK: 0002040705

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)7 (77.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KYNB

KYNTRA BIO, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

KYNB
KYNTRA BIO, INC.
Sep 6, 2026
Tax Payment(F)
Direct
22 shares at avg. $8.55$188.1
KYNB
KYNTRA BIO, INC.
Jun 6, 2026
Tax Payment(F)
Direct
52 shares at avg. $6.71$348.92
KYNB
KYNTRA BIO, INC.
Mar 6, 2026
Tax Payment(F)
Direct
60 shares at avg. $6.84$410.4
KYNB
KYNTRA BIO, INC.
Feb 3, 2026
Award(A)
Stock Option (Right to Buy)
Direct
26K shares-
FGEN
FIBROGEN INC
Dec 6, 2025
Tax Payment(F)
Direct
52 shares at avg. $8.42$437.84
FGEN
FIBROGEN INC
Sep 6, 2025
Tax Payment(F)
Direct
53 shares at avg. $12.10$641.3
FGEN
FIBROGEN INC
Jun 6, 2025
Tax Payment(F)
Direct
51 shares at avg. $7.83$399.458
FGEN
FIBROGEN INC
Mar 6, 2025
Tax Payment(F)
Direct
2.3K shares at avg. $0.39$906.75
FGEN
FIBROGEN INC
Jan 9, 2025
Award(A)
Stock Option (Right to Buy)
Direct
525K shares-

		Type	Shares	Price		Ownership
Sep 6, 2026	KYNB KYNTRA BIO, INC.	Tax Payment(F)	22	$8.55	$188	Direct
Jun 6, 2026	KYNB KYNTRA BIO, INC.	Tax Payment(F)	52	$6.71	$349	Direct
Mar 6, 2026	KYNB KYNTRA BIO, INC.	Tax Payment(F)	60	$6.84	$410	Direct
Feb 3, 2026	KYNB KYNTRA BIO, INC.	Award(A) Stock Option (Right to Buy)	26,000	-	-	Direct
Dec 6, 2025	FGEN FIBROGEN INC	Tax Payment(F)	52	$8.42	$438	Direct
Sep 6, 2025	FGEN FIBROGEN INC	Tax Payment(F)	53	$12.10	$641	Direct
Jun 6, 2025	FGEN FIBROGEN INC	Tax Payment(F)	51	$7.83	$399	Direct
Mar 6, 2025	FGEN FIBROGEN INC	Tax Payment(F)	2,325	$0.39	$907	Direct
Jan 9, 2025	FGEN FIBROGEN INC	Award(A) Stock Option (Right to Buy)	525,000	-	-	Direct

1-9 of 9 transactions

About DeLucia David

DeLucia David (SEC CIK 0002040705) files insider reports with the SEC as Chief Financial Officer of KYNTRA BIO, INC. (KYNB).

Signal8 holds 9 ownership filings by DeLucia David (1 Form 3, 8 Form 4), filed between Dec 18, 2024 and Sep 9, 2026. Those filings report 9 transactions, from Jan 9, 2025 to Sep 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DeLucia David's filings is in SAN FRANCISCO, CA.

Recent filings by DeLucia David

Sep 6, 2026: Tax withholding of KYNB shares (Form 4, code F).
Jun 6, 2026: Tax withholding of KYNB shares (Form 4, code F).
Mar 6, 2026: Tax withholding of KYNB shares (Form 4, code F).
Feb 3, 2026: Grant or award of KYNB derivative securities (Form 4, code A).
Dec 6, 2025: Tax withholding of FGEN shares (Form 4, code F).

Other insiders filing for KYNTRA BIO, INC. (KYNB)

Singer Andrew E., Director
Wettig Thane, CEO
Ho Maykin, Director
EDWARDS JEFFREY L, Director
Kauffman Michael, Director
Schoeneck James A, Director

How to read Form 4 transaction codes